title: Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma.
authors.affiliation: a Department of Oncology , Herlev and Gentofte Hospital, University of Copenhagen , Copenhagen , Denmark and.
authors.forename: Finn
authors.initials: F
authors.lastname: Ole Larsen
authors.affiliation: a Department of Oncology , Herlev and Gentofte Hospital, University of Copenhagen , Copenhagen , Denmark and.
authors.forename: Dan
authors.initials: D
authors.lastname: Taksony Solyom Hoegdall
authors.affiliation: b Department of Pathology , Herlev and Gentofte Hospital, University of Copenhagen , Copenhagen , Denmark.
authors.forename: Estrid
authors.initials: E
authors.lastname: Hoegdall
authors.affiliation: a Department of Oncology , Herlev and Gentofte Hospital, University of Copenhagen , Copenhagen , Denmark and.
authors.forename: Dorte
authors.initials: D
authors.lastname: Nielsen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001661:Biliary Tract Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000069287:Capecitabine / Q000008:administration & dosage; D000068818:Cetuximab / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate; D055815:Young Adult; D000093542:Gemcitabine
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D000068818:Cetuximab; D000093542:Gemcitabine